Century Therapeutics Inc — Cash Flow (NASDAQ:IPSC) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 89 M14.05 M88.35 M110.14 M 112.02 M Cash from investing activities 298.34 M13.13 M61.13 M47.48 M 115.75 M Cash from financing activities 417.77 M27.16 M9.72 M74.56 M -482 K Free cash flow 44.03 M-16.55 M74.61 M109.98 M 111.03 M

ニュース

TD Cowen initiates Century Therapeutics stock rating at Buy

Clear Street bestätigt Kaufempfehlung für Century Therapeutics und sieht erhebliches Kurspotenzial

Oracle, Palantir among market cap stock movers on Monday

Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know

Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler

Clear Street senkt Kursziel für Century Therapeutics auf 6,60 $

Century Therapeutics stock price target lowered to $6.60 at Clear Street

Century Therapeutics secures $135 million in private placement

FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug

Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain

Why Fast-paced Mover Century Therapeutics (IPSC) Is a Great Choice for Value Investors

Century Therapeutics appoints two new board members